Physicochemical Properties
| Molecular Formula | C7H12CLN3O3 |
| Molecular Weight | 221.64 |
| Exact Mass | 221.056 |
| CAS # | 70028-95-4 |
| Related CAS # | Ternidazole-d6 hydrochloride;1346599-62-9 |
| PubChem CID | 149468 |
| Appearance | White to off-white solid powder |
| Boiling Point | 419.9ºC at 760 mmHg |
| Flash Point | 207.8ºC |
| LogP | 1.807 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 3 |
| Heavy Atom Count | 14 |
| Complexity | 182 |
| Defined Atom Stereocenter Count | 0 |
| InChi Key | PTXLKVODAFRGDG-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C7H11N3O3.ClH/c1-6-8-5-7(10(12)13)9(6)3-2-4-11;/h5,11H,2-4H2,1H3;1H |
| Chemical Name | 3-(2-methyl-5-nitroimidazol-1-yl)propan-1-ol;hydrochloride |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| References |
[1]. Solid-state studies of the triclinic (Z' = 2) antiprotozoal drug ternidazole. J Pharm Sci. 2011 Jun;100(6):2258-66. [2]. Development and validation of a liquid chromatography with tandem mass spectrometry method for the determination of nitroimidazole residues in beeswax. J Sep Sci. |
Solubility Data
| Solubility (In Vitro) | DMSO: 250 mg/mL (1127.96 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.08 mg/mL (9.38 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.08 mg/mL (9.38 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 2.08 mg/mL (9.38 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 4.5118 mL | 22.5591 mL | 45.1182 mL | |
| 5 mM | 0.9024 mL | 4.5118 mL | 9.0236 mL | |
| 10 mM | 0.4512 mL | 2.2559 mL | 4.5118 mL |